Pune, India, April 08, 2019 (GLOBE NEWSWIRE) -- The improvement in the processes that enhance the efficacy of screening techniques that exploit gene-silencing mechanisms such as RNA interference (RNAi), have led the way to the emergence of CAS9 technology. The market for CAS9 technology market is projected to attain a CAGR of 11.30% in the forecast period from 2018 to 2023. The rise in experiments centered on genome editing have raised the need for CAS9 technologies. The capability to harness swift, lucrative and precise genetic manipulation is furthering the growth potential of the market.

The expansion of the biotechnology sector has been identified as an advantageous factor adding to the progress of the CAS9 technology market. The market for CAS9 technology is also spurred by the acceptance of gene therapy-based treatments. Though, the incorporation of the CAS9 high-precision technique into existing experimental workflows is expected to increase the market stake considerably in the coming period. Moreover, the inclination towards acceptance of anti-aging technology is expected to open up more rewarding avenues for growth of the CAS9 technology market. The progress in the development of cell therapies and new variations of the gene editing tool CRISPR-Cas9 are also leading to the swell in the level of investments that are being directed into the market through successful funding rounds by the up and coming firms. The diversification in the applicability of the CAS9 technique is expected to open up new areas for expansion in the upcoming years.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2064

Market Segmentation

The segmentation of the CAS9 technology market has been carried out on the basis of application, product type, delivery method, region, and end user. On the basis of product type, the CAS9 technology market has been segmented into consumables and vectors. By application, the CAS9 technology market has been segmented into disease models, genome engineering, and in vitro genetic depletion. On the basis of the delivery method, the CAS9 technology market has been segmented into viral delivery methods, physical delivery methods, and non-viral delivery methods. On the basis of end user, the CAS9 technology market has been segmented into academic & research institutes and biotechnology & pharmaceutical companies. The regions that are considered in the global study of the CAS9 technology market are the Americas, Asia Pacific, Europe, and the Middle East and Africa.

The Evolutionary Pace of Biotechnology & Pharmaceutical Companies to Reform Global CAS9 Technology Market

The regions covered in the global CAS9 Technology Market are the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas region has been credited with the biggest market share in 2017 and is expected to hold its lucrative position throughout the forecast period. It has been estimated that the market in the Americas region will exhibit a CAGR of 11.52% from 2018 to 2023 and accomplish a valuation above USD 1,300 million in the same period. The region is benefitted by the presence of factors such as the expansion in the biotechnology industry and the quick adoption of pioneering technologies in countries such Canada and the U.S. A remarkable level of growth has been perceived in the biotechnology sector in the U.S. in addition to the job prospects in the biotech sector which have increased by 6.7% in 2018 as compared to 2015 in the country. The European region controls the next chief stake in the CAS9 technology market. The intensification of CRISPR/CAS research activities in the pharmaceutical and biotechnology groups in the European region is expected to support the development of the CAS9 technology market in the upcoming period.

Key Players

The central players that are observed as the key influencers in the CAS9 technology market are abm Inc., GenScript, CRISPR Therapeutic, Intellia Therapeutics, Inc., Danaher Corporation (Integrated DNA Technologies, Inc.), GE Healthcare, Takara Bio, Inc., AstraZeneca, PLC, Bio-Rad Laboratories, Inc., New England Biolabs, Cellecta, Inc., OriGene Technologies, Inc., Merck KGaA, Lonza Group, and Thermo Fisher Scientific.

Browse Report @ https://www.marketresearchfuture.com/reports/cas9-technology-market-2064

Key Updates

Mar 2019 A group of engineers at theKeck Graduate Institute (KGI) of The Claremont Colleges and the UC have combined CRISPR with electronic transistors made from graphene to make a novel hand-held device that can spot particular genetic mutations in a matter of minutes. The device which has been named CRISPR-Chip, can be applied to quickly identify genetic diseases or to assess the exactness of gene-editing techniques.

Mar 2019 Aldevron, a principal manufacturing and contract development organization that serves the biotech industry, has announced the launch of GMP SpyFi Cas9 Nuclease for commercial and clinical applications. SpyFi Cas9 Nuclease, is the direct effect of a joint venture with Integrated DNA Technologies, Inc. (IDT). The benefits of SpyFi Cas9 Nuclease consist of less off-target effects that are collective with clinically pertinent on-target activity.

Related Reports:

Pharma Knowledge Management Software Market, By Software (Android, Windows, iOS), By Deployment Type (On Premises, Cloud, Hybrid), By End-Users (Agricultural Biotechnology, Environmental Biotechnology, Academics, Forensic Biotechnology) - Forecast 2023. The global pharma knowledge management software market is expected to grow at USD ~2 Billion by 2023, at ~17% of CAGR between 2017 and 2023.

https://www.marketresearchfuture.com/reports/pharma-knowledge-management-software-market-4269

Virtual Reality in Therapy Market, By Device (Head mount, Gesture Control), By Technology (Non-Immersive, Fully Immersive), By Application (Phobia Treatment, Robotic Surgery) - Forecast 2023. The global VR in therapy market is expected to reach approximately USD 3.9 billion by the end of 2023 with 32% CAGR during forecast period 2017-2023.

https://www.marketresearchfuture.com/reports/virtual-reality-therapy-market-4345

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com